Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
Orally Bioavailable LHRH Antagonistic Peptidomimetics: Treatment of Endometriosis, Uterus Myoma, BPH and Malignant Disorders such as Breast and Prostate Cancer More
Superior Alternative to Pads and Tampons More
Cliovelle - a low dose Estradiol / Progestin combination product for treatment of menopausal disorders. More
Currently, LTS has two matrix formulation under development varying in their manufacturing process More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Compatible Permeation Enhancement Excipients: Enhancing Transmucosal and Transdermal Drug Delivery More
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
DNA-Based Therapeutic Angiogenesis / Protein Therapeutic for Thrombocytopenia / Therapeutic Cancer Vaccine Targeting HER2/neu / Hardy Kiwi Extract for Immune Hypersensitivity More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2011 - 7 pages - $3,835
Jun 2008 - $2,500
Dec 2007 - 56 pages - $495
May 2011 - 5 pages - $500
Jan 2010 - $75
Dec 2010 - 93 pages - $500
Feb 2011 - 41 pages - $125
Apr 2011 - 106 pages - $3,500
Nov 2007 - $2,500
Sep 2011 - 43 pages - $99
Your selection
- Therapeutic target
- Endocrinology del
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Amenorrahea
- Androgen deficiency
- Endocrine system
- Estrogen replacement
- Growth disorders
- Hormonal disorder (other)
- Hormone replacement therapy
- Hurler's syndrome
- Hypogonadism
- Hypothalamic
- Menopause
- Pancreatic exocrine insufficiency
- Sex hormone (other)
- Testosterone replacement
- Thyroid disorders
- Turner's syndrome
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us